Clinical Trial Update: Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of activated T lymphocytes (ATL) in hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Activated T Lymphocytes (ATL) (Activated T Lymphocytes)

Snippet

Sponsor: Lukas Biomedical Inc. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING